MedTrace Logo

Hämeenlinna Metabolic Syndrome Research Program: Surrogate Indicators for Atherosclerosis

NCT01119404 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2010-05-11

No results posted yet for this study

Summary

Mechanisms that link metabolic syndrome to atherosclerosis are incompletely understood. As a part of Hämeenlinna Metabolic Syndrome Research Program (HMS) surrogate indicators for atherosclerosis are studied in 120 men with metabolic syndrome, 120 men with coronary heart disease and 80 physically active controls and in different settings.

Conditions

Sponsors & Collaborators

  • Linnan Klinikka Oy

    collaborator OTHER

  • Mehiläinen Hämeenlinna, Finland

    collaborator UNKNOWN

  • Finnish Red Cross Blood Service

    collaborator OTHER

  • Kanta-Häme Central Hospital

    lead OTHER_GOV

Principal Investigators

  • Ari K Palomäki, MD PhD · Central Hospital of Kanta-Häme

  • Kalevi Oksanen, MD PhD · Central Hospital of Kanta-Häme

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-06-30
Primary Completion
2014-06-30
Completion
2014-12-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01119404 on ClinicalTrials.gov